Ghent University Academic Bibliography

Journal Article
A1
open access

Absolute oral bioavailability, quantitative toxicokinetics and metabolite profiling of alternariol and alternariol monomethyl ether in pigs

Danica den Hollander, Siegrid De Baere (UGent) , Celestien Holvoet, Mathias Devreese (UGent) , Gunther Antonissen (UGent) , Ann Martens (UGent) , Kristel Demeyere (UGent) , Kris Audenaert (UGent) , Evelyne Meyer (UGent) and Siska Croubels (UGent)

(2025) ARCHIVES OF TOXICOLOGY.

Add to list

Journal Article
A1
open access

In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids

Liam De Vrieze (UGent) , Sara E. Walton, Eline Pottie (UGent) , Donna Papsun, Barry K. Logan, Alex J. Krotulski, Christophe Stove (UGent) and Marthe Vandeputte (UGent)

(2024) ARCHIVES OF TOXICOLOGY. 98(9). p.2999-3018

Add to list

Journal Article
A1
open access

Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs

Liesl Janssens (UGent) , Katleen Van Uytfanghe (UGent) , Jeffrey B. Williams, Kirk W. Hering, Donna M. Iula and Christophe Stove (UGent)

(2024) ARCHIVES OF TOXICOLOGY. 98(8). p.2619-2630

Add to list

Journal Article
A1
open access

Interpreting mono- and poly-SCRA intoxications from an activity-based point of view : JWH-018 equivalents in serum as a comparative measure

Liesl Janssens (UGent) , Michaela J. Sommer, Katharina Elisabeth Grafinger, Maren Hermanns-Clausen, Volker Auwärter and Christophe Stove (UGent)

(2024) ARCHIVES OF TOXICOLOGY. 98(10). p.3337-3350

Add to list

Journal Article
A1
open access

Off-target activity of NBOMes and NBOMe analogs at the mu opioid receptor

Marie Deventer (UGent) , Mattias Persson, Antonio Laus, Eline Pottie (UGent) , Annelies Cannaert (UGent) , Graziella Tocco, Henrik Green and Christophe Stove (UGent)

(2023) ARCHIVES OF TOXICOLOGY. 97(5). p.1367-1384

Add to list

Characterization of recent non-fentanyl synthetic opioids via three different in vitro mu-opioid receptor activation assays

Marthe Vandeputte (UGent) , Mattias Persson, Donna Walther, Svante Vikingsson, Robert Kronstrand, Michael H. Baumann, Henrik Green and Christophe Stove (UGent)

(2022) ARCHIVES OF TOXICOLOGY. 96(3). p.877-897

Add to list

Journal Article
A1
open access

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Marthe Vandeputte (UGent) , Nick Verougstraete (UGent) , Donna Walther, Grant C. Glatfelter, Jeroen Malfliet, Michael H. Baumann, Alain Verstraete (UGent) and Christophe Stove (UGent)

(2022) ARCHIVES OF TOXICOLOGY. 96(6). p.1865-1880

Add to list

Journal Article
A1
open access

Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites

Liesl Janssens (UGent) , Simon Hudson, David M. Wood, Caitlin Wolfe, Paul I. Dargan and Christophe Stove (UGent)

(2022) ARCHIVES OF TOXICOLOGY. 96(11). p.2935-2945

Add to list

Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238

Melissa F. Fogarty, Marthe Vandeputte (UGent) , Alex J. Krotulski, Donna Papsun, Sara E. Walton, Christophe Stove (UGent) and Barry K. Logan

(2022) ARCHIVES OF TOXICOLOGY. 96(6). p.1701-1710

Add to list

Journal Article
A1
open access

Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid

Marthe Vandeputte (UGent) , Alex J. Krotulski, Donna Walther, Grant C. Glatfelter, Donna Papsun, Sara E. Walton, Barry K. Logan, Michael H. Baumann and Christophe Stove (UGent)

(2022) ARCHIVES OF TOXICOLOGY. 96(6). p.1845-1863

Academic Bibliography

Absolute oral bioavailability, quantitative toxicokinetics and metabolite profiling of alternariol and alternariol monomethyl ether in pigs

In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids

Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs

Interpreting mono- and poly-SCRA intoxications from an activity-based point of view : JWH-018 equivalents in serum as a comparative measure

Off-target activity of NBOMes and NBOMe analogs at the mu opioid receptor

Characterization of recent non-fentanyl synthetic opioids via three different in vitro mu-opioid receptor activation assays

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites

Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238

Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid

Contents

Support

Contact